US Patent RE40812 Nasal calcitonin formulation
Patent RE40812 was granted and assigned to Unigene Laboratories, Inc. on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
William Stern0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+535 characters)
Article
Patent abstract
A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said composition being in a form table for nasal administration. A liquid pharmaceutical composition is provided for nasal administration of calcitonin or an acid addition salt thereof. The nasal pharmaceutical formulations contain a component selected from the group consisting of citric acid, citric acid salt and a combination thereof.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent RE040812 Nasal calcitonin formulation US Patent RE40812 Nasal calcitonin formulation
Infobox
Patent Number
RE04081200
Patent Number
RE4081200
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0408120
Date of Patent
June 30, 2009
0Patent Application Number
107743580
Date Filed
February 5, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0408120
Date of Patent
June 30, 2009
0Patent Application Number
107743580
Date Filed
February 5, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent RE040812 Nasal calcitonin formulation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
RE040812
Date of patent
June 30, 2009
Patent application number
10774358
Date Filed
February 5, 2004
Patent primary examiner
Find more entities like US Patent RE40812 Nasal calcitonin formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.